Deadline Approaching: Apply for the Fierce AI Innovation Awards
calendar
Biotech

Parabilis’ upsized $670M IPO breaks new for record for biotechs

Parabilis Medicines’ IPO has lived up to the hype—securing $670 million for the largest listing in the biotech sector’s history.
James Waldron Jun 10, 2026 4:36am
Sanofi

Sanofi halts phase 3 autoimmune trial early over lackluster data

Jun 10, 2026 4:25am
FranchiseKeyvisualsOncologyLevel2Digital-nonepng

Could engaging the immune system improve AML outcomes?

Brought to you by Ipsen
glue scissors art supplies

Novartis sticks 2nd deal with Orionis, this one worth up to $1.4B

Jun 10, 2026 8:21am
Magnifying glass focusing on number 2026 with target icon on yellow background

Despite headwinds, biotech industry charges forward behind M&A

Jun 9, 2026 12:41pm
rollercoaster ride theme park scary crazy

Parabilis ups planned IPO haul to record-setting $637M

Jun 9, 2026 10:22am
More News

Lilly licenses AlzeCure Alzheimer’s asset for $1B biobucks

Jun 9, 2026 10:16am

ADA: AZ’s oral GLP-1 shows ‘competitive efficacy’ in phase 2

Jun 9, 2026 9:48am

Bial bails after Parkinson’s fail, axing asset over phase 2 miss

Jun 9, 2026 5:22am

GSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer

Jun 9, 2026 4:41am